Back to AI Artemis Investment Management LLP

BIO

13 quarters

Position history for AIArtemis Investment Management LLP's holdings in Bio-Rad Laboratories, Inc.

No. Artemis Investment Management exited its BIO (Bio-Rad Laboratories) position in Q4 2022. Its Q3 2022 13F listed 194,607 shares worth $81.3M. Artemis Investment Management held BIO in 12 quarterly 13F filings before exiting.

Final Value

$0

Final Shares

0

Total Value Change

-$40.7M

Total Shares Change

-112,553

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q4
Latest
Exited
0
-100.0%
$00.0%$420.49
0
2022-Q3
Decreased
194,607
-0.6%
$81.3M0.9%$417.14
0
2022-Q2
Increased
195,787
+97.6%
$97M1.0%$495.00
68
2022-Q1
Decreased
99,096
-29.2%
$55.7M0.4%$563.23
0
2021-Q4
Increased
139,977
+10.5%
$105.7M0.8%$755.57
47
2021-Q3
Increased
126,702
+12.3%
$94.4M0.7%$745.95
47
2021-Q2
Increased
112,875
+34.8%
$72.8M0.6%$644.29
54
2021-Q1
Decreased
83,740
-23.1%
$47.8M0.5%$571.17
0
2020-Q4
Decreased
108,871
-18.3%
$63.6M0.7%$582.94
0
2020-Q3
Decreased
133,228
-32.8%
$68.6M0.9%$515.46
0
2020-Q2
Decreased
198,258
-23.4%
$89.7M1.2%$451.49
0
2020-Q1
Increased
258,641
+129.8%
$89.9M1.6%$350.56
76
2019-Q4
First report
112,553
-
$40.7M0.5%$370.03
0

Other major holders of BIO: FMR LLC, First Eagle Investment Management, LLC

Optional analytics helps us improve. How it’s used